The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Inactivated Vaccines Market Between 2026 And 2030?
The inactivated vaccines market has shown consistent expansion in recent years. Its size is anticipated to expand from $6.37 billion in 2025 to $6.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.9%. This past growth can be ascribed to an increase in the incidence of infectious diseases, advances in virology research, government support for immunization, the broadening of healthcare infrastructure, and public awareness campaigns promoting vaccination.
The inactivated vaccines market is projected to experience robust expansion over the coming years. This market is set to reach $8.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this anticipated growth include an expanding elderly demographic, improved healthcare accessibility in developing economies, innovations in vaccine administration methods, a surge in worldwide immunization efforts, and the increasing use of multi-dose and combination vaccines. Key trends foreseen for this period encompass improvements in vaccine composition, the broadening of cold chain infrastructure, a rising need for childhood vaccines, the expansion of governmental immunization schemes, and the ongoing creation of combination vaccines.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
What Leading Drivers Are Supporting The Inactivated Vaccines Market Expansion?
The expanding occurrence of infectious diseases is projected to stimulate the growth of the inactivated vaccine market in the foreseeable future. These diseases are ailments stemming from pathogens such as bacteria, viruses, fungi, or parasites, which are transmissible between individuals, leading to diverse symptoms and health complications. Tuberculosis is a form of infectious disease. Inactivated vaccines leverage non-living pathogens to trigger an immune response, effectively averting conditions like polio, hepatitis A, and influenza. For example, a report from November 2023 by the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that the count of tuberculosis patients in the USA climbed from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Hence, the escalating prevalence of infectious diseases is fueling the growth of the inactivated vaccine market.
How Are Different Segments Classified In The Inactivated Vaccines Market Segment Analysis?
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
What Trends Are Shaping The Future Of The Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are concentrating on expanding product launches and securing regulatory approvals to bolster their global vaccine portfolios and address increasing immunization requirements. For instance, in April 2024, Sanofi S.A., a France-based healthcare company, introduced Verorab, its inactivated rabies vaccine, in the UK, making it available for all age groups in both pre-exposure and post-exposure circumstances. This launch emphasizes the company’s sustained efforts to broaden its range of inactivated vaccines and strengthen its global immunization offerings. The development also indicates rising investments and increasing regulatory momentum around inactivated vaccine development and approvals. As more companies advance similar products and diversify their portfolios, these strategic initiatives are collectively fostering substantial growth in the inactivated vaccines market, supporting broader protection against infectious diseases.
Who Are The Companies Driving Activity In The Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd.
Get The Full Inactivated Vaccines Market Report:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Which Region Is The Top Contributor To The Inactivated Vaccines Market By Share?
North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Inactivated Vaccines Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2026, By The Business Research Company
Inactivated Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model